Marinus Pharmaceuticals reported $657.2M in Market Capitalization for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 3.91B 222.46M
Adamas Pharmaceuticals ADMS:US 239.75M 41.19M
ALKERMES ALKS:US 4.98B 1.04B
Amgen AMGN:US $ 140.05B 3.22B
Aptinyx Inc APTX:US $ 192.93M 7.74M
Arena Pharmaceuticals ARNA:US $ 4.16B 41.38M
Biogen BIIB:US $ 42.17B 9.96B
Eisai 4523:JP 3239.99B 1039.76B
Enanta Pharmaceuticals ENTA:US $ 888.79M 106.09M
Esperion Therapeutics ESPR:US $ 596.26M 193.51M
Gilead Sciences GILD:US $ 86.36B 4.99B
Intercept Pharmaceuticals ICPT:US $ 663.03M 98.97M
Intra Cellular Therapies ITCI:US $ 3.32B 573.64M
Marinus Pharmaceuticals MRNS:US $ 657.2M 90.12M
Minerva Neurosciences NERV:US $ 99.11M 25.63M
Neurocrine Biosciences NBIX:US $ 9.2B 7.62M
Ptc Therapeutics PTCT:US $ 2.98B 347.22M
Regeneron Pharmaceuticals REGN:US $ 59.5B 8.81B
Sarepta Therapeutics SRPT:US $ 6.2B 282.45M
Supernus Pharmaceuticals SUPN:US $ 1.64B 250.8M
UCB UCB:BB 17.15B 715.78M
Vertex Pharmaceuticals VRTX:US $ 52.2B 3.42B
YTE INCY:US $ 18.5B 632.77M
Zogenix ZGNX:US $ 964.44M 125.02M